🇺🇸 FDA

Company profile · Sponsor

SOLENO

SOLENO THERAPEUTICS INC

SLNO · NYSE pharma REDWOOD CITY, CA, USA
Pipeline
2
Drugs
1
Patents
0

Quick answer

SOLENO (SLNO) is a pharma company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 1 drug, and 0 patents to this profile..

Company facts

Ticker SLNO
Exchange NYSE
Company type pharma
Headquarters REDWOOD CITY, CA, USA
SEC CIK 0001484565

Pipeline (2)

Search pipeline →

  1. DCCR

    SOLENO

    Prader-Willi Syndrome

    phase 3 small molecule active

    4 trials

  2. DCCR (diazoxide choline) extended-release tablets

    SOLENO

    SH2B1 Deficiency Obesity

    phase 2 small molecule active

    1 trial

Drugs (1)

Search drugs →

  1. diazoxide choline

    VIOKAT

    ORAL approved

    N07X

Frequently asked questions

What is SOLENO?

SOLENO (SLNO) is a pharma company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 1 drug, and 0 patents to this profile..

What pipeline programs does SOLENO sponsor?

We track 2 ClinicalTrials.gov-linked programs for SOLENO, including DCCR and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does SOLENO company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.